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Summary
Objective: Osteoarthritis (OA) is characterized by damaged articular cartilage and changes in subchondral bone. Previous work demonstrated
aggrecanase-2 deﬁcient (ADAMTS5/) mice to be protected from cartilage damage induced by joint instability. This study analyzed whether
this protective effect on cartilage is also reﬂected in the subchondral bone structure.
Methods: Right knee joints from 10-week old male wild type (WT) and ADAMTS5/ mice received transection of the medial meniscotibial
ligament to induce OA, whereas left knees were left unoperated. After 8 weeks knee joints were scanned by micro-CT. The proximal tibia was
selected for further analysis. Histology was performed to evaluate cartilage damage and osteoclast presence.
Results: ADAMTS5/ joints had a signiﬁcantly thinner subchondral plate and less epiphyseal trabecular bone compared to WT joints. His-
tology conﬁrmed previous ﬁndings that ADAMTS5/ mice have signiﬁcantly less cartilage damage than WT in the instability-induced OA
model. Although the subchondral bone plate became signiﬁcantly thicker at the medial tibial plateau in operated joints of both genotypes,
the percentage increase was signiﬁcantly smaller in ADAMTS5/ mice (WT: 20.7 4.7%, ADAMTS5/: 8.3 1.2% compared to the
left unoperated control joint). In ADAMTS5/ animals a signiﬁcant decrease was found in both Oc.N./BS and Oc.S./BS. Finally, in WT
but not in ADAMTS5/ mice a signiﬁcant correlation was found between medial subchondral bone plate thickness and cartilage damage
at the medial tibial plateau.
Conclusion: ADAMTS5/ joints that were protected from cartilage damage showed minor changes in the subchondral bone structure, in
contrast to WT mice where substantial changes were found. This ﬁnding suggests links between the process of cartilage damage and sub-
chondral bone changes in instability-induced OA.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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In the articulated joint, bone and cartilage are in close prox-
imity. Although a sharp border exists between the two tis-
sues there is evidence that they are in fact connected1e3.
Furthermore, there is evidence that osteoblasts and chon-
drocytes can inﬂuence each other’s metabolism4,5, espe-
cially in a disease such as osteoarthritis (OA)6e9. In OA,
cartilage is damaged and apparent changes take place in
the structure of the subchondral bone10. Although the rela-
tion between cartilage damage and subchondral bone
changes is still controversial, the subchondral bone is
thought to play an important role in the progression and per-
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636subchondral bone becomes sclerotic, which may be caused
by, or might have an effect on, the overlying cartilage11,12.
In cartilage the extracellular matrix (ECM) is composed of
two main structural elements, collagen type II and aggre-
can. The collagen ﬁbrils confer strength and stiffness,
whereas aggrecan’s function is to retain water inside the
ECM, thereby offering resistance to compressive forces
and conferring the shock-absorptive capacity of cartilage.
Aggrecan is a large proteoglycan consisting of a protein
core backbone consisting of three globular domains, G1,
G2 and G3. The G1 domain is responsible for the linkage
to hyaluronic acid, thus making large aggregates containing
up to 100 aggrecan monomers. Between domains G2 and
G3, glycosaminoglycan (GAG) side chains (chondroitin sul-
phate and keratan sulphate) are attached to the protein
core. In normal cartilage, there is a steady state between
synthesis and degradation of aggrecan, but in OA acceler-
ated proteolytic cleavage is observed13e16. Fragments of
aggrecan have been identiﬁed in the synovial ﬂuid of pa-
tients with various forms of arthritis, including OA17,18.
When aggrecan is cleaved, the carboxy-terminal tail of the
637Osteoarthritis and Cartilage Vol. 17, No. 5protein containing the GAGs diffuses out of the cartilage
and water is no longer retained. The structural integrity of
the cartilage matrix is thus affected19.
A major cleavage site for speciﬁc enzymes including ag-
grecanases that are able to cleave aggrecan is located in
the region between G1 and G2, termed the interglobular do-
main, between amino acids 373 and 374. To date, three of
such aggrecanases, termed ‘A Disintegrin And Metallopro-
teinase with ThromboSpondin-like motifs’ or ADAMTS
were found to be able to cleave aggrecan: ADAMTS120,21,
ADAMTS422 and ADAMTS523 (a useful overview of the cur-
rently available data on the latter can be found in24).
ADAMTS4 and -5 possess the greatest cleavage efﬁciency
and inhibition of their activity is known to prevent aggrecan
degradation in osteoarthritic cartilage25,26. ADAMTS4 was
initially thought to be more detrimental to cartilage health
since its rate of aggrecan cleavage was approximately
two-fold higher than ADAMTS527. However since in articu-
lar cartilage of mice its aggrecanase activity was not de-
tected, ADAMTS5 is now thought to be the main
aggrecanase responsible for aggrecan degradation in artic-
ular cartilage28. Previously, deletion of ADAMTS5 in mice
prevented cartilage degradation after induction of OA29.
Compared to WT mice, ADAMTS5 deﬁcient, but not
ADAMTS1 or -430 deﬁcient mice were protected from carti-
lage damage and aggrecan loss after OA induction through
surgical instability of the medial meniscus.
Since ADAMTS5 deﬁcient mice are protected from carti-
lage damage, and since it is well known that changes in
subchondral bone occur in OA, we questioned whether
the differences found in cartilage damage between WT
and ADAMTS5 deﬁcient mice are also reﬂected in the sub-
chondral bone structure of these mice.
Previously, we demonstrated that subtle changes in sub-
chondral bone structure can be quantiﬁed using micro-com-
puted tomography (micro-CT) analysis31. Therefore, the
aim of this study was to compare the changes in subchon-
dral bone structure following destabilizing the medial menis-
cus in WT and ADAMTS5 deﬁcient mice using micro-CT.MethodsGENERATION OF ADAMTS5 KNOCKOUT MICEADAMTS5 deﬁcient (ADAMTS5/) mice used in these studies were
generated as described earlier29 from inbred 129SvEv-Brd mice carrying
a cre/loxP-type conditional KO (CKO) allele of the ADAMTS5 gene (Lexicon
Genetics, The Woodlands, TX). The conditional allele contained loxP sites
ﬂanking exon 3 so that cre recombination resulted in deletion of 56 amino
acids encoded by exon 3, including the majority of the enzyme active site.
The ADAMTS5/ mouse line was produced by crossing CKO mice with
protamine-cre (prot-cre)-transgenic mice (Lexicon Genetics), which resulted
in cre-mediated deletion of exon 3 in the sperm of male offspring carrying
both the mutant ADAMTS5 and prot-cre alleles. The deletion was conﬁrmed
by polymerase chain reaction (PCR) from tail DNA29.SURGICAL INDUCTION OF OA BY DESTABILIZATION OF
THE MEDIAL MENISCUS (DMM)All studies were performed with approval of the Wyeth Institutional Animal
Care and Use Committee. Knee joint instability was induced surgically
in age-matched male 129S6/SvEv mice. At 10 weeks of age, 10
ADAMTS5/ and 10 WT mice were anesthetized with 250 mg/kg intraper-
itoneal tribromoethanol (Sigma Aldrich, Milwaukee, WI) and instability of the
right knee joint was induced by transection of the anterior attachment of the
medial meniscus to the tibial plateau32. Left knee joints were left intact and
are termed ‘left unoperated control joints’. All mice were weight bearing fol-
lowing recovery from anaesthesia. Buprenorphine (Buprenex, Reckitt&Col-
man, Kingston-upon-Hill, UK) was administered pre- and postoperatively.
A subset of age-matched 5 ADAMTS5/ and 5 WT animals was not oper-
ated and was considered na€ıve. Body weight of all mice was measured three
times during the experiment: at 8 weeks, 10 weeks (the time point of DMM)and 18 weeks of age. All animals were sacriﬁced at 8 weeks post surgery (18
weeks of age). In total, 30 mice were used. All research was done in accor-
dance with all applicable federal guidelines and institutional policies.HISTOLOGICAL ANALYSESCoronal (frontal) histological sections were taken through the joint at
70 mm intervals, stained with Safranin-O and cartilage damage was scored
by two blinded observers using a modiﬁcation of a published mouse scoring
system by Chambers et al.33. A score of 0 represents normal cartilage;
0.5¼ loss of Safranin-O without structural changes; 1¼ roughened articular
surface and small ﬁbrillations; 2¼ ﬁbrillation down to the layer immediately
below the superﬁcial layer and some loss of surface lamina; and 3¼mild
(<20%), 5¼moderate (20e80%) and 6¼ severe (>80%) loss of articular
cartilage30. Scores of 4 (erosion to bone) were not a feature of this model.
Histological scores were assigned to four quadrants (medial tibial plateau,
medial femoral condyle, lateral tibial plateau, and lateral femoral condyle)
of the left and right knee joints at all sectioned levels to obtain a summed
OA score for the whole knee joint, or for the medial and lateral tibial plateau
separately.
Since micro-CT analysis (see next paragraph) cannot distinguish calciﬁed
cartilage from bone, the thickness of the calciﬁed cartilage was measured
separately by histological analyses. Microphotographs were taken of tolui-
dine-blue stained medial and lateral tibial plateaus and the thickness of the
calciﬁed cartilage was measured using Bioquant Osteo v7.20 (Bioquant,
Nashville, TN). This programme measures the thickness of an indicated
area (i.e., the calciﬁed cartilage) every 5 mm over a distance of 400 mm, pro-
ducing roughly 80 measurements, which were averaged afterwards. Osteo-
clasts were visualized using histochemical staining for tartrate-resistant acid
phosphatase (TRAP) activity as described previously34, using Gill’s haema-
toxylin as counter stain. Osteoclast quantiﬁcation included osteoclast sur-
face/bone surface (Oc.S./BS, in %) and osteoclast number/bone surface
(Oc.N./BS), again using Bioquant Osteo v7.20.MICRO-COMPUTED TOMOGRAPHIC SCANNING AND
QUANTIFICATION OF BONE MORPHOMETRIC PARAMETERSPrior to sectioning, knee joints were scanned using the Skyscan 1072 mi-
cro-CT scanner (Skyscan, Kontich, Belgium) with a voxel size of 10 mm. In
order to distinguish calciﬁed tissue from non-calciﬁed tissue, the recon-
structed greyscale images were segmented by an automated algorithm us-
ing local thresholds35. In order to study subchondral bone the epiphysis of
the tibia was chosen as the region of interest. The outline of the epiphysis
was manually selected using 3D data analysis software (CTAnalyser, Sky-
scan) and care was taken not to select outgrowing mineralized osteophytes.
The volume of the medial tibial osteophytes was determined separately us-
ing the same procedure.
The subchondral bone plate and trabeculae of the epiphysis were sepa-
rated using in-house developed software. For each cross-section in the 3D
dataset, a virtual mask of the total bone was created, which was used to
identify the bone marrow regions in the original image. These marrow re-
gions were then expanded into a mask of the total marrow cavity. Bone in-
side the total marrow cavity is considered trabecular bone, the remainder
is cortex. The programme is available upon request, including help on how
to use it.
Bone morphometric parameters of the thus obtained bone structures were
determined using the freely available software package 3D-Calculator (http://
www.erasmusmc.nl/orthopaedie/research/labor/downloads). The following
3D-morphometric parameters were calculated for the trabecular compart-
ments: trabecular bone volume fraction (Trab BV/TV), which is the ratio of
trabecular bone volume (Trab BV) over endocortical total volume (TV, i.e.,
Trab BV plus marrow cavity volume), trabecular thickness (Tb.Th., in mm),
trabecular spacing (Tb.Sp., in mm), connectivity density (CD), which calcu-
lates the number of trabecular connections per unit volume36 and structure
model index (SMI), indicating whether trabeculae have a rod-like (value
near 3) or plate-like (value near 0) shape37.
The thickness of the medial and lateral side of the subchondral bone plate
(in mm) was measured using the same algorithm as used for determining
Tb.Th. A subset (0.5 mm mediolateral width, 1.0 mm ventrodorsal length)
of the weight-bearing region at the medial and lateral side of the tibial plateau
was taken as the region of interest.
The same location was used to measure the bone volume fraction of the
underlying subchondral trabecular bone (Sb BV/TV). Figure 1 shows a sche-
matic overview of the analyzed bone structures.DATA ANALYSISStatistical analyses utilized a nonparametric ManneWhitney U test
(GraphPad Prism, San Diego, CA). Differences between medial and lateral
parameters within the same joint or within the same animal were analyzed
with the Wilcoxon matched paired test.
Fig. 1. Selection procedure of tibial epiphysis for 3D-morphometric
analysis. The epiphysis was manually selected as representative of
subchondral bone, and outgrowing osteophytes were excluded.
Epiphyseal trabeculae were separated from the subchondral
bone plate and trabecular bone morphometric parameters were cal-
culated (see Table I). A subset of the medial and lateral subchon-
dral bone plate and underlying epiphyseal trabecular bone were
analyzed separately, as indicated for the medial side.
638 S. M. Botter et al.: Subchondral bone changes in ADAMTS5L/L micePearson’s coefﬁcient of regression was used to calculate correlations be-
tween cartilage damage and subchondral bone plate thickness. In all cases,
P< 0.05 was considered statistically signiﬁcant. In all graphs, the error bars
depict standard error of the mean (S.E.M.).Results
The gross appearance of ADAMTS5/ mice was not
different from the WT mice, as reported previously29. How-
ever, during the study the average bodyweight of the
ADAMTS5/ mice was less compared to the WT mice
(at 18 weeks of age, WT: 27.6 0.7 g; ADAMTS5/:
24.3 1.0 g, P¼ 0.01). In one ADAMTS5/ mouse, oste-
omyelitis was diagnosed histologically in the right (DMM)
knee joint. Another ADAMTS5/ mouse had bone mor-
phometric values and cartilage damage values more than
three standard deviations below the group average. These
mice were left out of all analyses.CHANGES IN CARTILAGE IN WT AND ADAMTS5/ MICEThe summed OA score of the whole knee joint showed
a signiﬁcant increase in OA in right DMM knee joints com-
pared to the left unoperated control knee joints in both ge-
notypes [Fig. 2(A)]. However, the amount of cartilage
damage in ADAMTS5/ mice was signiﬁcantly lower
compared to WT mice (WT: 19.3 2.7, ADAMTS5/:
10.7 1.5, P¼ 0.02), in accordance with previously re-
ported results29.
When the OA scores of the medial and lateral tibial pla-
teau were considered separately, WT mice showed a signif-
icant increase in cartilage damage at both the medial and
lateral side, although the lateral increase was signiﬁcantly
lower [Fig. 2(B)]. The same pattern was found in
ADAMTS5/ mice, but again lower damage scores com-
pared to WT were observed, signiﬁcantly at the lateral side.
Similar to DMM joints of WT mice, in ADAMTS5/ mice
the damage at the lateral tibial plateau was signiﬁcantly
lower compared to the medial side.CHANGES IN BONE IN WT AND ADAMTS5/ MICEAfter DMM, mineralized osteophytes were observed at
the medial side in all tibiae of both genotypes, but not atthe lateral side [Fig. 3(A)]. The average volume of
these medial osteophytes was larger in WT mice, although
the difference was not statistically signiﬁcant (WT:
0.053 0.004 mm3, ADAMTS5/: 0.042 0.004 mm3,
P¼ 0.09). None of the unoperated Ctrl joints had
osteophytes.
Pronounced sclerosis of the subchondral bone plate was
found at the medial tibia in WT mice, on both micro-CT
scans and histological images [Fig. 3(A, B)] whereas in
ADAMTS5/ mice sclerosis seemed to be less. These
apparent differences were quantiﬁed further using micro-
CT analysis. The bone morphometric data proved that in
WT mice the thickness of the subchondral plate was in-
creased at the medial side compared to the unoperated
left knee joint [Fig. 4(A)]. In ADAMTS5/ mice this in-
crease was observed as well, albeit signiﬁcantly less com-
pared to the increase seen in WT mice. Of note, the
absolute subchondral bone plate thickness in the left unop-
erated control joints was already signiﬁcantly higher in WT
mice compared to ADAMTS5/ mice, both at the medial
and lateral side. This difference was observed in the group
of na€ıve animals as well (data not shown). Therefore, we
calculated the relative increase in plate thickness, ex-
pressed as a percentage. The percental increase was
also found to be signiﬁcantly higher in WT mice
[Fig. 4(A), WT: 20.7 4.7%, ADAMTS5/: 8.3 1.2%,
P¼ 0.01]. Neither WT nor ADAMTS5/ mice showed
an increase in plate thickness at the lateral side of the tibial
plateau.
Contrary to these apparent changes, the DMM proce-
dure did not affect the subchondral trabecular bone
structure in either strain: the total Trab BV/TV of the
epiphysis was not changed compared to left unoperated
control joints, as well as Tb.Th., Tb.Sp., CD and SMI
(Table I). However, ADAMTS5/ mice had signiﬁcantly
lower Trab BV/TV and Tb.Th. compared to the WT
animals.
To examine whether Trab BV/TV might be changed
locally, we measured the subchondral trabecular bone
volume fraction (Sb BV/TV) directly underneath the me-
dial and lateral regions of the subchondral bone plate in
the weight-bearing region of the tibial plateau [Figs. 1
and 4(B)]. In WT mice no differences were found between
the DMM joints and the left unoperated control joints, but
in DMM joints of ADAMTS5/ mice a signiﬁcant de-
crease was measured at the medial, but not lateral side
compared to unoperated joints. In addition, a signiﬁcantly
lower Sb BV/TV was noted in left unoperated control
joints of ADAMTS5/ mice compared to WT animals,
as seen before for the whole Trab BV/TV of the
epiphysis.
To speciﬁcally look further into the medial differences
between genotypes, we quantiﬁed the presence of osteo-
clasts at the medial tibia in both WT and ADAMTS5/
mice (Fig. 5). In WT animals, DMM did not have an effect
on the amount or size of osteoclasts present in the me-
dial tibia (Oc.N./BS: Ctrl 0.70 0.24, DMM 0.71 0.18,
Oc.S./BS: Ctrl 4.30 1.79, DMM 4.80 1.05). Surpris-
ingly, in ADAMTS5/ mice we found a signiﬁcant de-
crease in both Oc.N./BS as Oc.S./BS, indicating less
osteoclasts (Oc.N./BS: Ctrl 0.70 0.22, DMM 0.17
0.10 P< 0.05, Oc.S./BS: Ctrl 4.29 1.43, DMM 0.96
0.52 P< 0.05).
Finally, no signiﬁcant differences were found between
thicknesses of calciﬁed cartilage of left unoperated control
and DMM joints in either strain, neither at the medial nor
at the lateral side [Fig. 4(C)].
S
u
m
m
e
d
 
O
A
 
s
c
o
r
e
0
5
10
15
20
25
WT ADAMTS5-/-
Ctrl Ctrl DMM
O
A
 
s
c
o
r
e
0
2
4
6
8
10
Ctrl DMM
WT ADAMTS5-/-
Ctrl DMM Ctrl DMM
WT ADAMTS5-/-
Medial tibial plateau Lateral tibial plateau
P<0.01 P<0.01
P<0.01
B
A
P=0.02P<0.01
P<0.01
P<0.01
P=0.01
ADAMTS5-/- + DMM
WT + DMM
DMM
DMM Ctrl
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SUBCHONDRAL BONE PLATE THICKNESSWhen medial subchondral bone plate thicknesses were
related to the amount of cartilage damage found at the me-
dial tibial plateau a signiﬁcant correlation was found in WT
but not in ADAMTS5/ mice (r2¼ 0.26, P¼ 0.01). This
correlation became more clear when the summed OA score
was considered (r2¼ 0.42, P< 0.01). Correlations betweenlateral subchondral bone plate thicknesses and lateral car-
tilage damage did not reach signiﬁcance in either strain.
Discussion
This study revealed that ADAMTS5/ mice, next to be-
ing protected from cartilage damage, also show less
changes in subchondral bone structure after induction of joint
ADAMTS5-/-WT
Ctrl DMM Ctrl DMM
A
B
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0
c
g
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Fig. 3. (A) Representative cross-sections of tibiae from WT and ADAMTS5/ mice, both left unoperated control (Ctrl) and right DMM. The
inset shows a 3D reconstruction of a proximal tibia with a plane indicating the location from which the cross-sections were taken. Epiphysis (E),
metaphysis (M) and growth plate (dotted line) are indicated, as well as the medial (Med) and lateral (Lat) tibial plateau. Subchondral sclerosis
was found in the medial region of the epiphysis (arrows), and medial osteophytes were observed as well (arrowheads). (B) Histological images
of the medial tibia from DMM WT and ADAMTS5/ mice, stained with toluidine-blue. Please note the pronounced sclerosis of the subchon-
dral bone plate in the WT mice, whereas ADAMTS5/ mice only showed mild sclerosis. Magniﬁcation 100. C¼ cartilage, O¼ osteophyte,
G¼ growth plate.
640 S. M. Botter et al.: Subchondral bone changes in ADAMTS5L/L miceinstability. Following instability, both WT and ADAMTS5/
mice had an increase in subchondral plate thickness,
although the increase was signiﬁcantly less in ADAMTS5/
mice. These ﬁndings were entirely attributed to the subchon-
dral bone plate, since other calciﬁed structures such as the
calciﬁed cartilage or the subchondral trabeculae were not
changed. Furthermore, only at the site where the amount of
cartilage damage was highest did the subchondral bone
plate thickness change, since analysis of the bone plate
thickness at the lateral side of the epiphysis showed no differ-
ences between left unoperated control and right DMM knee
joints. Finally, since bone and cartilage changes were found
to be speciﬁcally correlated at the medial side only, this pro-
vides a clear indication that changes in bone and cartilage
are linked in this animal model.
Although it became clear from our results that changes in
cartilage and bone took place in a synchronized fashion, the
cross-sectional design of the study makes it difﬁcult to con-
clude whether the changes in bone were a consequence or
cause of the cartilage damage. Several explanations for the
observed correlation might therefore be possible. First, via
mechanical interactions, where cartilage damage leads to
softening of the cartilage, thereby changing the loading of
the underlying bone and bone metabolism. Second, viametabolic interactions in which chondrocytes in the articular
cartilage might be able to inﬂuence bone turnover in the
subchondral bone plate or vice versa. Several studies
have shown direct means of contact between normal artic-
ular cartilage and normal bone2,3,38,39 and chondrocytes
and osteoblasts are able to inﬂuence each other’s metabo-
lism4,5. In a pathological situation such as OA, the cross-talk
between bone cells and chondrocytes might be disturbed
leading to the observed effects. Possible cross-talk candi-
date molecules in this respect are prostaglandin E240e42,
IL-69,43e45, and oncostatin M46,47. In this respect, it is inter-
esting that calcitonin, well known for its inhibitory effects on
osteoclasts and therefore bone turnover48, has been shown
to be chondroprotective49,50, although there is still debate
whether this protective effect is mediated directly on chon-
drocytes51,52 or indirectly via the bone53,54. In case calcito-
nin acts solely by inhibiting osteoclasts, this might also
include osteoclasts at other locations in the knee joint,
such as the synovium. Macrophages in OA synovial ﬂuid
and synovial ﬁbroblasts have been shown to differentiate
into osteoclasts as well55e57. This way, calcitonin may di-
rectly inhibit the osteoclasts’ collagen type II degradative
abilities which play a role in the process of endochondral
ossiﬁcation58.
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Table I
Trabecular bone parameters from male WTand ADAMTS5/mice. All parameters were derived from trabecular bone of the entire epiphysis
of left unoperated control and right DMM tibiae, 10 weeks after the operation. Numbers shown are averages S.E.M. *P< 0.05, **P< 0.01
between genotypes and corresponding joints
Parameter WT ADAMTS5/
Ctrl DMM Ctrl DMM
Trab BV/TV (%) 36.3 0.4 36.2 0.4 33.8 0.5** 33.3 0.5**
Tb.Th. (mm) 75.0 0.6 74.9 0.7 69.2 0.3** 69.2 0.5**
Tb.Sp. (mm) 181.0 2.7 180.1 2.7 170.2 2.6* 175.2 4.1
CD 183.9 6.8 182.6 8.9 200.6 11.2 187.8 6.9
SMI 3.00 0.02 3.00 0.07 3.06 0.03 3.09 0.04
642 S. M. Botter et al.: Subchondral bone changes in ADAMTS5L/L miceIn our mice, the absence of ADAMTS5 leads to impair-
ment of aggrecan degradation and cartilage damage in
a stressful environment, such as induced by DMM. Chon-
drocyte homeostasis might therefore be maintained for
a longer period, and subchondral bone biology is not af-
fected as much as seen in the WT mice. This argument is
substantiated by the fact that the ADAMTS5/ had signif-
icantly less OA through 6 months post-DMM (unpublished
observations). The fact that the ADAMTS5/ mice still
had a detectable amount of cartilage damage is probably
due to the possibility that ADAMTS5 is not solely responsi-
ble for joint destruction59.
Finally, although the background of both mouse geno-
types is the same and no obvious phenotypical differences
were noted, we did observe subtle differences in the pheno-
type of the bones. Generally, ADAMTS5/ mice had
a thinner subchondral bone plate and less trabecular
bone with thinner trabeculae. This could not be attributed
to differences in osteoclast activity since the CtrlFig. 5. Examples of TRAP-stained osteoclasts in the medial tibia of WT a
DMM. Osteoclasts in the subchondral bone (black arrowheads) were obs
teoclasts beneath the growth plate (white arrowheads). Please note that
were observed despite the presence of osteoclasts beneath the gro
ADAMTS5/ joints and the subchondral sclerosis after DMM in the
bone plate, G¼ g(unoperated) values of Oc.N./BS and Oc.S./BS were virtu-
ally equal. Since ADAMTS5 is also expressed in
bone60,61 it may therefore play an important role in bone bi-
ology as well, possibly in the process of endochondral ossi-
ﬁcation, which may perhaps evolve less efﬁcient, ending up
with less bone. As such, these differences in bone architec-
ture might affect joint mechanics and subsequently inﬂu-
ence the stresses present in cartilage after DMM.
The relation between changes in subchondral bone plate
thickness and cartilage damage was found for WT animals
only. The reason for this was that in ADAMTS5/ mice
the data was too scattered to obtain a signiﬁcant correlation,
and although some of the mice having a relatively high car-
tilage damage score (but still lower compared to most WT
animals) did seem to have a thicker subchondral bone plate
this relation was not signiﬁcant. Most probably, the changes
in cartilage in ADAMTS5/ mice were too small to have
an effect on bone or vice versa. Furthermore, although
the observed correlation is signiﬁcant in WT animals, it isnd ADAMTS5/ mice, both left unoperated control (Ctrl) and right
erved in Ctrl and DMM joints of both genotypes, in addition to os-
in DMM joints of ADAMTS5/ mice, very few if any osteoclasts
wth plate. Also note the thinner subchondral bone plate in the
WT joint. Magniﬁcation 100. C¼ cartilage, SBP¼ subchondral
rowth plate.
643Osteoarthritis and Cartilage Vol. 17, No. 5still quite low. Possibly, other factors besides cartilage dam-
age may also contribute to the observed relation.
Currently, we do not have a suitable explanation as to
why so few osteoclasts were found in DMM joints of the
ADAMTS5/ animals only. Although the results ﬁt with
the increase in subchondral bone plate thickness they
do not ﬁt with the observed medial decrease in Sb BV/
TV in ADAMTS5/ mice. We could exclude errors in
the staining procedure since osteoclasts underneath in
the growth plate were clearly visible (i.e., stained bright
red) in all of the sections analyzed. Possibly, at the time-
point of measurement (i.e., 8 weeks after DMM) bone
turnover in the ADAMTS5/ joints had already ceased
and as a response to repair osteoclasts had already mi-
grated to other areas. Another explanation might be that
in DMM joints of ADAMTS5/ mice the rate of osteo-
blastic activity might have been very low in trabeculae,
unable to compensate for the osteoclastic activity present
right after DMM. A clear limitation of this study was that
due to our choice to perform histology on parafﬁn embed-
ded (and therefore decalciﬁed) knee joints we were also
not able to perform Goldner trichome staining to visualize
osteoid, or analyze any dynamic osteoblast activity using
ﬂuorescent markers.
In the current study, the weight of the ADAMTS5/
mice was signiﬁcantly lower than the WT. This difference
in weight was not typical since all other studies have primar-
ily shown no difference in weight, or occasionally, an in-
crease in weight (unpublished results) and highlight the
spurious results that can be observed in weight changes
when knockout mice are utilized with group sizes of 10.
However, to solely attribute the lower bone volume fraction
to a lower body weight is highly unlikely since the lightest
WT mouse still had more trabecular bone compared to
the heaviest ADAMTS5/ mouse (WT: 23.8 g, BV/TV
35.6%, ADAMTS5/: 28.8 g, BV/TV 31.1%).
Compared to other models of OA, our results are in line
with spontaneous models such as the STR/ort and
STR1 N mice62,63 and DunkineHartley guinea pigs64,65,
which develop OA spontaneously, and in which subchon-
dral sclerosis was observed as well. We previously pub-
lished data in which an initial decrease in subchondral
bone plate thickness was noted in mice66 and dogs67 after
induction of OA. Other studies conﬁrm these ﬁndings and
in addition, report the amount of subchondral bone to in-
crease later on68e71. This biphasic pattern in bone turn-
over might reﬂect the disease status, where early stages
are marked by bone loss, followed by an anabolic re-
sponse resulting in bone sclerosis in more advanced
stages of disease. In the present study we found sclerosis
of the subchondral bone as well as fully mineralized osteo-
phytes, arguing for a more advanced disease stage and
indicating that OA, surgically induced by DMM, develops
rather quickly.
In conclusion, in mice in which joint instability was surgi-
cally induced, we found an increase in subchondral bone
plate thickness. However, in ADAMTS5/ mice this in-
crease was signiﬁcantly lower, in accordance with a lower
amount of cartilage damage. These ﬁndings again stress
the importance of ADAMTS5 in OA biology and link the pro-
cess of cartilage damage with changes in subchondral bone
dynamics.Conﬂict of interest
The authors declare that they have no conﬂict of interest.Acknowledgements
Thanks to Moise´s Rivera-Bermu´dez, Tracey Blanchet, Jen-
nifer Tavares, Diane Peluso and Erwin Waarsing for techni-
cal expertise.References
1. Imhof H, Breitenseher M, Kainberger F, Rand T, Trattnig S. Importance
of subchondral bone to articular cartilage in health and disease. Top
Magn Reson Imaging 1999;10:180e92.
2. Burstein D, Velyvis J, Scott KT, Stock KW, Kim YJ, Jaramillo D, et al.
Protocol issues for delayed Gd(DTPA)(2-)-enhanced MRI (dGEMRIC)
for clinical evaluation of articular cartilage. Magn Reson Med 2001;45:
36e41.
3. Lyons TJ, McClure SF, Stoddart RW, McClure J. The normal human
chondro-osseous junctional region: evidence for contact of uncalciﬁed
cartilage with subchondral bone and marrow spaces. BMC Musculos-
kelet Disord 2006;7.
4. Nakaoka R, Hsiong SX, Mooney DJ. Regulation of chondrocyte differen-
tiation level via co-culture with osteoblasts. Tissue Eng 2006;12:
2425e33.
5. Jiang J, Nicoll SB, Lu HH. Co-culture of osteoblasts and chondrocytes
modulates cellular differentiation in vitro. Biochem Biophys Res Com-
mun 2005;338:762e70.
6. Westacott CI, Webb GR, Warnock MG, Sims JV, Elson CJ. Alteration of
cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum
1997;40:1282e91.
7. Westacott C. Interactions between subchondral bone and cartilage in
OA. Cells from osteoarthritic bone can alter cartilage metabolism.
J Musculoskelet Neuronal Interact 2002;2:507e9.
8. Sanchez C, Deberg MA, Piccardi N, Msika P, Reginster JY,
Henrotin YE. Subchondral bone osteoblasts induce phenotypic
changes in human osteoarthritic chondrocytes. Osteoarthritis Carti-
lage 2005;13:988e97.
9. Sanchez C, Deberg MA, Piccardi N, Msika P, Reginster JY,
Henrotin YE. Osteoblasts from the sclerotic subchondral bone down-
regulate aggrecan but upregulate metalloproteinases expression by
chondrocytes. This effect is mimicked by interleukin-6, -1beta and on-
costatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis Carti-
lage 2005;13:979e87.
10. Day JS, van der Linden JC, Bank RA, Ding M, Hvid I, Sumner DR, et al.
Adaptation of subchondral bone in osteoarthritis. Biorheology 2004;
41:359e68.
11. Burr DB. Increased biological activity of subchondral mineralized tissues
underlies the progressive deterioration of articular cartilage in osteoar-
thritis. J Rheumatol 2005;32:1156e8.
12. Lajeunesse D. The role of bone in the treatment of osteoarthritis. Oste-
oarthritis Cartilage 2004;12(Suppl A):S34e8.
13. Sandy JD, Neame PJ, Boynton RE, Flannery CR. Catabolism of aggre-
can in cartilage explants. Identiﬁcation of a major cleavage site within
the interglobular domain. J Biol Chem 1991;266:8683e5.
14. Plaas A, Osborn B, Yoshihara Y, Bai Y, Bloom T, Nelson F, et al. Aggre-
canolysis in human osteoarthritis: confocal localization and biochem-
ical characterization of ADAMTS5ehyaluronan complexes in articular
cartilages. Osteoarthritis Cartilage 2007;15:719e34.
15. Sandy JD, Verscharen C. Analysis of aggrecan in human knee cartilage
and synovial ﬂuid indicates that aggrecanase (ADAMTS) activity is re-
sponsible for the catabolic turnover and loss of whole aggrecan
whereas other protease activity is required for C-terminal processing
in vivo. Biochem J 2001;358:615e26.
16. LarkMW, BayneEK, Flanagan J, Harper CF, Hoerrner LA, HutchinsonNI,
et al. Aggrecan degradation in human cartilage. Evidence for both ma-
trix metalloproteinase and aggrecanase activity in normal, osteoar-
thritic, and rheumatoid joints. J Clin Invest 1997;100:93e106.
17. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of ag-
grecan fragments in human synovial ﬂuid. Evidence for the involve-
ment in osteoarthritis of a novel proteinase which cleaves the Glu
373-Ala 374 bond of the interglobular domain. J Clin Invest 1992;
89:1512e6.
18. Lohmander LS, Neame PJ, Sandy JD. The structure of aggrecan frag-
ments in human synovial ﬂuid. Evidence that aggrecanase mediates
cartilage degradation in inﬂammatory joint disease, joint injury, and
osteoarthritis. Arthritis Rheum 1993;36:1214e22.
19. Chockalingam PS, Zeng W, Morris EA, Flannery CR. Release of hyalur-
onan and hyaladherins (aggrecan G1 domain and link proteins) from
articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or
ADAMTS-5 (aggrecanase 2). Arthritis Rheum 2004;50:2839e48.
20. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K.
Molecular cloning of a gene encoding a new type of metalloprotei-
nase-disintegrin family protein with thrombospondin motifs as an
inﬂammation associated gene. J Biol Chem 1997;272:556e62.
644 S. M. Botter et al.: Subchondral bone changes in ADAMTS5L/L mice21. Kuno K, Okada Y, Kawashima H, Nakamura H, Miyasaka M, Ohno H,
et al. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS
Lett 2000;478:241e5.
22. Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, et al.
Puriﬁcation and cloning of aggrecanase-1: a member of the ADAMTS
family of proteins. Science 1999;284:1664e6.
23. Abbaszade I, Liu RQ, Yang F, Rosenfeld SA, Ross OH, Link JR, et al.
Cloning and characterization of ADAMTS11, an aggrecanase from
the ADAMTS family. J Biol Chem 1999;274:23443e50.
24. Fosang AJ, Rogerson FM, East CJ, Stanton H. ADAMTS-5: the story so
far. Eur Cell Mater 2008;15:11e26.
25. Malfait AM, Liu RQ, Ijiri K, Komiya S, Tortorella MD. Inhibition of ADAM-
TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic
cartilage. J Biol Chem 2002;277:22201e8.
26. Tortorella MD, Malfait AM, Deccico C, Arner E. The role of ADAM-TS4
(aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of car-
tilage degradation. Osteoarthritis Cartilage 2001;9:539e52.
27. Tortorella MD, Liu RQ, Burn T, Newton RC, Arner E. Characterization of
human aggrecanase 2 (ADAM-TS5): substrate speciﬁcity studies and
comparison with aggrecanase 1 (ADAM-TS4). Matrix Biol 2002;21:
499e511.
28. Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT,
et al. ADAMTS5 is the major aggrecanase in mouse cartilage in
vivo and in vitro. Nature 2005;434:648e52.
29. Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, et al.
Deletion of active ADAMTS5 prevents cartilage degradation in a mu-
rine model of osteoarthritis. Nature 2005;434:644e8.
30. Glasson SS, Askew R, Sheppard B, Carito BA, Blanchet T, Ma HL, et al.
Characterization of and osteoarthritis susceptibility in ADAMTS-4-
knockout mice. Arthritis Rheum 2004;50:2547e58.
31. Botter SM, van Osch GJ, Waarsing JH, Day JS, Verhaar JA,
Pols HA, et al. Quantiﬁcation of subchondral bone changes in
a murine osteoarthritis model using micro-CT. Biorheology 2006;
43:379e88.
32. Glasson SS, Blanchet TJ, Morris EA. The surgical destabilization of the
medial meniscus (DMM) model of osteoarthritis in the 129/SvEv
mouse. Osteoarthritis Cartilage 2007;15:1061e9.
33. Chambers MG, Cox L, Chong L, Suri N, Cover P, Bayliss MT, et al. Ma-
trix metalloproteinases and aggrecanases cleave aggrecan in differ-
ent zones of normal cartilage but colocalize in the development of
osteoarthritic lesions in STR/ort mice. Arthritis Rheum 2001;44:
1455e65.
34. Erlebacher A, Derynck R. Increased expression of TGF-beta 2 in oste-
oblasts results in an osteoporosis-like phenotype. J Cell Biol 1996;
132:195e210.
35. Waarsing JH, Day JS, Weinans H. An improved segmentation method
for in vivo microCT imaging. J Bone Miner Res 2004;19:1640e50.
36. Odgaard A, Gundersen HJ. Quantiﬁcation of connectivity in cancellous
bone, with special emphasis on 3-D reconstructions. Bone 1993;14:
173e82.
37. Hildebrand T, Ruegsegger P. Quantiﬁcation of bone microarchitecture
with the Structure Model Index. Comput Methods Biomech Biomed
Eng 1997;1:15e23.
38. Imhof H, Sulzbacher I, Grampp S, Czerny C, Youssefzadeh S,
Kainberger F. Subchondral bone and cartilage disease: a rediscov-
ered functional unit. Invest Radiol 2000;35:581e8.
39. Malinin T, Ouellette EA. Articular cartilage nutrition is mediated by sub-
chondral bone: a long-term autograft study in baboons. Osteoarthritis
Cartilage 2000;8:483e91.
40. Raisz LG. Prostaglandins and bone: physiology and pathophysiology.
Osteoarthritis Cartilage 1999;7:419e21.
41. Masuko-Hongo K, Berenbaum F, Humbert L, Salvat C, Goldring MB,
Thirion S. Up-regulation of microsomal prostaglandin E synthase 1
in osteoarthritic human cartilage: critical roles of the ERK-1/2 and
p38 signaling pathways. Arthritis Rheum 2004;50:2829e38.
42. Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, et al.
Superinduction of cyclooxygenase-2 activity in human osteoarthritis-
affected cartilage. Inﬂuence of nitric oxide. J Clin Invest 1997;99:
1231e7.
43. Sanchez C, Deberg MA, Bellahcene A, Castronovo V, Msika P,
Delcour JP, et al. Phenotypic characterization of osteoblasts from
the sclerotic zones of osteoarthritic subchondral bone. Arthritis Rheum
2008;58:442e55.
44. de Hooge AS, van de Loo FA, Bennink MB, Arntz OJ, de Hooge P, Van
den Berg WB. Male IL-6 gene knock out mice developed more ad-
vanced osteoarthritis upon aging. Osteoarthritis Cartilage 2005;13:
66e73.
45. Massicotte F, Lajeunesse D, Benderdour M, Pelletier JP, Hilal G,
Duval N, et al. Can altered production of interleukin-1beta, inter-
leukin-6, transforming growth factor-beta and prostaglandin E(2)
by isolated human subchondral osteoblasts identify two subgroups
of osteoarthritic patients. Osteoarthritis Cartilage 2002;10:
491e500.46. Sanchez C, Deberg MA, Burton S, Devel P, Reginster JY, Henrotin YE.
Differential regulation of chondrocyte metabolism by oncostatin M and
interleukin-6. Osteoarthritis Cartilage 2004;12:801e10.
47. Lisignoli G, Piacentini A, Toneguzzi S, Grassi F, Cocchini B, Ferruzzi A,
et al. Osteoblasts and stromal cells isolated from femora in rheuma-
toid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leu-
kaemia inhibitory factor and oncostatin M. Clin Exp Immunol 2000;
119:346e53.
48. Huebner AK, Schinke T, Priemel M, Schilling S, Schilling AF,
Emeson RB, et al. Calcitonin deﬁciency in mice progressively results
in high bone turnover. J Bone Miner Res 2006;21:1924e34.
49. Papaioannou NA, Triantaﬁllopoulos IK, Khaldi L, Krallis N, Galanos A,
Lyritis GP. Effect of calcitonin in early and late stages of experimen-
tally induced osteoarthritis. A histomorphometric study. Osteoarthritis
Cartilage 2007;15:386e95.
50. El Hajjaji H, Williams JM, Devogelaer JP, Lenz ME, Thonar EJ,
Manicourt DH. Treatment with calcitonin prevents the net loss of col-
lagen, hyaluronan and proteoglycan aggregates from cartilage in the
early stages of canine experimental osteoarthritis. Osteoarthritis Car-
tilage 2004;12:904e11.
51. Sondergaard BC, Wulf H, Henriksen K, Schaller S, Oestergaard S,
Qvist P, et al. Calcitonin directly attenuates collagen type II degrada-
tion by inhibition of matrix metalloproteinase expression and activity
in articular chondrocytes. Osteoarthritis Cartilage 2006;14:759e68.
52. Karsdal MA, Tanko LB, Riis BJ, Sondergard BC, Henriksen K,
Altman RD, et al. Calcitonin is involved in cartilage homeostasis: is cal-
citonin a treatment for OA? Osteoarthritis Cartilage 2006;14:617e24.
53. Lin Z, Pavlos NJ, Cake MA, Wood DJ, Xu J, Zheng MH. Evidence that
human cartilage and chondrocytes do not express calcitonin receptor.
Osteoarthritis Cartilage 2008;16:450e7.
54. Behets C, Williams JM, Chappard D, Devogelaer JP, Manicourt DH. Ef-
fects of calcitonin on subchondral trabecular bone changes and on os-
teoarthritic cartilage lesions after acute anterior cruciate ligament
deﬁciency. J Bone Miner Res 2004;19:1821e6.
55. Adamopoulos IE, Danks L, Itonaga I, Locklin RM, Sabokbar A,
Ferguson DJ, et al. Stimulation of osteoclast formation by inﬂamma-
tory synovial ﬂuid. Virchows Arch 2006;449:69e77.
56. Danks L, Sabokbar A, Gundle R, Athanasou NA. Synovial macropha-
geeosteoclast differentiation in inﬂammatory arthritis. Ann Rheum
Dis 2002;61:916e21.
57. Adamopoulos IE, Sabokbar A, Wordsworth BP, Carr A, Ferguson DJ,
Athanasou NA. Synovial ﬂuid macrophages are capable of osteoclast
formation and resorption. J Pathol 2006;208:35e43.
58. Mackie EJ, Ahmed YA, Tatarczuch L, Chen KS, Mirams M. Endochon-
dral ossiﬁcation: how cartilage is converted into bone in the develop-
ing skeleton. Int J Biochem Cell Biol 2008;40:46e62.
59. East CJ, Stanton H, Golub SB, Rogerson FM, Fosang AJ. ADAMTS-5
deﬁciency does not block aggrecanolysis at preferred cleavage sites
in the chondroitin sulfate-rich region of aggrecan. J Biol Chem 2007;
282:8632e40.
60. Nakamura M, Sone S, Takahashi I, Mizoguchi I, Echigo S, Sasano Y.
Expression of versican and ADAMTS1, 4, and 5 during bone develop-
ment in the rat mandible and hind limb. J Histochem Cytochem 2005;
53:1553e62.
61. Lind T, McKie N, Wendel M, Racey SN, Birch MA. The hyalectan
degrading ADAMTS-1 enzyme is expressed by osteoblasts and
up-regulated at regions of new bone formation. Bone 2005;36:
408e17.
62. Wachsmuth L, Engelke K. High-resolution imaging of osteoarthritis us-
ing microcomputed tomography. Methods Mol Med 2004;101:
231e48.
63. Walton M, Elves MW. Bone thickening in osteoarthrosis. Observations
of an osteoarthrosis-prone strain of mouse. Acta Orthop Scand
1979;50:501e6.
64. Dedrick DK, Goulet R, Huston L, Goldstein SA, Bole GG. Early bone
changes in experimental osteoarthritis using microscopic computed
tomography. J Rheumatol Suppl 1991;27:44e5.
65. Layton MW, Goldstein SA, Goulet RW, Feldkamp LA, Kubinski DJ,
Bole GG. Examination of subchondral bone architecture in experi-
mental osteoarthritis by microscopic computed axial tomography. Ar-
thritis Rheum 1988;31:1400e5.
66. Botter SM, van Osch GJ, Waarsing JH, van der Linden JC, Verhaar JA,
Pols HA, et al. Cartilage damage pattern in relation to subchondral
plate thickness in a collagenase-induced model of osteoarthritis. Os-
teoarthritis Cartilage 2008;16:506e14.
67. Sniekers YH, Intema F, Lafeber FP, van Osch GJ, van Leeuwen JP,
Weinans H, et al. A role for subchondral bone changes in the process
of osteoarthritis; a micro-CT study of two canine models. BMC Muscu-
loskelet Disord 2008;9:20.
68. Batiste DL, Kirkley A, Laverty S, Thain LM, Spouge AR, Holdsworth DW.
Ex vivo characterization of articular cartilage and bone lesions in a rab-
bit ACL transection model of osteoarthritis using MRI and micro-CT.
Osteoarthritis Cartilage 2004;12:986e96.
645Osteoarthritis and Cartilage Vol. 17, No. 569. Dedrick DK, Goldstein SA, Brandt KD, O’Connor BL, Goulet RW,
Albrecht M. A longitudinal study of subchondral plate and trabecular
bone in cruciate-deﬁcient dogs with osteoarthritis followed up for 54
months. Arthritis Rheum 1993;36:1460e7.
70. Dedrick DK, Goulet RW, O’Connor BL, Brandt KD. Preliminary re-
port: increased porosity of the subchondral plate in an acceleratedcanine model of osteoarthritis. Osteoarthritis Cartilage 1997;5:
71e4.
71. Hayami T, Pickarski M, Zhuo Y, Wesolowski GA, Rodan GA, Duong lT.
Characterization of articular cartilage and subchondral bone changes
in the rat anterior cruciate ligament transection and meniscectomized
models of osteoarthritis. Bone 2006;38:234e43.
